Literature DB >> 17312101

Cutting Edge: TFII-I controls B cell proliferation via regulating NF-kappaB.

Todd Ashworth1, Ananda L Roy.   

Abstract

The multifunctional transcription factor TFII-I physically and functionally interacts with Bruton's tyrosine kinase in murine B cells. However, the downstream functions of TFII-I in B cells are unknown. Toward achieving this goal, we established stable posttranscriptional silencing of TFII-I in WEHI-231 immature murine B cells, which undergoes growth arrest and apoptosis either upon anti-IgM or TGF-beta signaling. In this study, we show that TFII-I promotes growth arrest of cells in a signal-dependent manner. Unlike control cells, B cells exhibiting loss of TFII-I function fail to undergo arrest upon signaling due to up-regulation of c-Myc expression and concomitant down-regulation of both p21 and p27. Loss of TFII-I is also associated with simultaneous increase in nuclear c-rel and decrease in p50 homodimer binding. Thus, besides controlling c-myc transcription, TFII-I controls B cell proliferation by regulating both nuclear translocation of c-rel and DNA-binding activity of p50 NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17312101     DOI: 10.4049/jimmunol.178.5.2631

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Genome-wide targeting of the epigenetic regulatory protein CTCF to gene promoters by the transcription factor TFII-I.

Authors:  Rodrigo Peña-Hernández; Maud Marques; Khalid Hilmi; Teijun Zhao; Amine Saad; Moulay A Alaoui-Jamali; Sonia V del Rincon; Todd Ashworth; Ananda L Roy; Beverly M Emerson; Michael Witcher
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

Review 2.  BTK inhibitors in chronic lymphocytic leukemia: a glimpse to the future.

Authors:  M Spaargaren; M F M de Rooij; A P Kater; E Eldering
Journal:  Oncogene       Date:  2014-06-23       Impact factor: 9.867

Review 3.  Biochemistry and biology of the inducible multifunctional transcription factor TFII-I: 10 years later.

Authors:  Ananda L Roy
Journal:  Gene       Date:  2011-10-21       Impact factor: 3.688

4.  Loss of cell surface TFII-I promotes apoptosis in prostate cancer cells stimulated with activated α₂ -macroglobulin.

Authors:  U K Misra; Y M Mowery; G Gawdi; S V Pizzo
Journal:  J Cell Biochem       Date:  2011-06       Impact factor: 4.429

5.  Identification of additional loci associated with antibody response to Mycobacterium avium ssp. Paratuberculosis in cattle by GSEA-SNP analysis.

Authors:  Marcello Del Corvo; Mario Luini; Alessandra Stella; Giulio Pagnacco; Paolo Ajmone-Marsan; John L Williams; Giulietta Minozzi
Journal:  Mamm Genome       Date:  2017-09-01       Impact factor: 2.957

6.  Characterization of a novel interaction between transcription factor TFII-I and the inducible tyrosine kinase in T cells.

Authors:  Catarina Sacristán; Stefan A Schattgen; Leslie J Berg; Stephen C Bunnell; Ananda L Roy; Yvonne Rosenstein
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

7.  Essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.

Authors:  Badam Enkhmandakh; Aleksandr V Makeyev; Lkhamsuren Erdenechimeg; Frank H Ruddle; Nyam-Osor Chimge; Maria Isabel Tussie-Luna; Ananda L Roy; Dashzeveg Bayarsaihan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-24       Impact factor: 11.205

8.  IL-2-inducible T-cell kinase (ITK) finds another (dance) partner...TFII-I.

Authors:  Avery August
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

Review 9.  Regulation of RNA Polymerase II Transcription Initiation and Elongation by Transcription Factor TFII-I.

Authors:  Niko Linzer; Alexis Trumbull; Rukiye Nar; Matthew D Gibbons; David T Yu; John Strouboulis; Jörg Bungert
Journal:  Front Mol Biosci       Date:  2021-05-13

10.  Dermatan Sulfate Is a Potential Regulator of IgH via Interactions With Pre-BCR, GTF2I, and BiP ER Complex in Pre-B Lymphoblasts.

Authors:  Jongmin Lee; Jung-Hyun Rho; Michael H Roehrl; Julia Y Wang
Journal:  Front Immunol       Date:  2021-05-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.